Medical Device News Magazine

ACC, AHA Issue Updated Chest Pain Data Standards

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Chest pain is one of the leading reasons for adult emergency room visits in the United States, accounting for more than 7 million visits annually. Properly identifying and treating dangerous and life-threatening causes of chest pain is critical.

The 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Chest Pain underscored the need to reach a consensus for the definitions of chest pain. In an update to the 2021 guideline, this 2022 document standardizes related data elements for consistent reporting on chest pain cases and establishes a new definition set focusing on serious cardiovascular causes of chest pain and acute myocardial infarction.

Included in the document, data elements are grouped into three broad categories: chest pain, myocardial injury and myocardial infarction. Chest pain symptoms have traditionally been labeled “typical” or “atypical,” however, to define their expansive nature, the document divides chest pain syndromes into three categories: “cardiac,” “possible cardiac” and “noncardiac” based on the 2021 chest pain guideline. In addition, the writing committee writes that uniform definitions for myocardial infarction are needed to ensure accurate reporting of cardiac events across all clinical trials and registries. Data elements for procedure-related myocardial injury and procedure-related myocardial infarction are included in the document. The standardized definitions and data elements should be broadly applicable across patient care settings, electronic health records, quality and performance improvement initiatives, registries and public reporting programs.

The 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction will publish online in the Journal of the American College of Cardiology and Circulation: Cardiovascular Quality and Outcomes on Tuesday, August 30, 2022 at 2:00 p.m. ET. It was developed in collaboration with the American College of Emergency Physicians and the Society for Cardiac Angiography and Interventions, and endorsed by the Society for Academic Emergency Medicine.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”